The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1–T2 Breast Cancer

Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy

(2013) Lynn T. Dengel et al.   ANNALS OF SURGICAL ONCOLOGY

Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research

(2013) N. Bouganim et al.   BREAST CANCER RESEARCH AND TREATMENT

International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases

(2013) Tuomo J. Meretoja et al.   BREAST CANCER RESEARCH AND TREATMENT

Incorporation of Sentinel Lymph Node Metastasis Size Into a Nomogram Predicting Nonsentinel Lymph Node Involvement in Breast Cancer Patients With a Positive Sentinel Lymph Node

(2011) Elizabeth A. Mittendorf et al.   ANNALS OF SURGERY

Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN

(2011) R.F.D. van la Parra et al.   EJSO

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Implication of Extracapsular Invasion of Sentinel Lymph Nodes in Breast Cancer: Prediction of Nonsentinel Lymph Node Metastasis

(2010) Takaaki Fujii et al.   WORLD JOURNAL OF SURGERY